FTSE All-Share
5.326,71
PKT
+11,13
PKT
+0,21
%
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 07.03.14 | Unilever Underweight | JP Morgan Chase & Co. | |
| 07.03.14 | Unilever Underweight | JP Morgan Chase & Co. | |
| 07.03.14 | HSBC Conviction Buy List | Goldman Sachs Group Inc. | |
| 07.03.14 | Shell (ex Royal Dutch Shell) Neutral | JP Morgan Chase & Co. | |
| 07.03.14 | Barclays buy | Citigroup Corp. | |
| 07.03.14 | BP Neutral | UBS AG | |
| 06.03.14 | BP buy | S&P Capital IQ | |
| 06.03.14 | Standard Chartered neutral | Independent Research GmbH | |
| 06.03.14 | Glencore neutral | Independent Research GmbH | |
| 06.03.14 | Glencore Outperform | Credit Suisse Group | |
| 06.03.14 | Standard Chartered Underperform | Credit Suisse Group | |
| 06.03.14 | Standard Chartered Neutral | Goldman Sachs Group Inc. | |
| 06.03.14 | Standard Chartered Underweight | Morgan Stanley | |
| 06.03.14 | Standard Chartered Neutral | JP Morgan Chase & Co. | |
| 06.03.14 | Glencore kaufen | S&P Capital IQ | |
| 06.03.14 | Standard Chartered neutral | Deutsche Bank AG | |
| 06.03.14 | Standard Chartered buy | UBS AG | |
| 06.03.14 | AstraZeneca buy | UBS AG | |
| 05.03.14 | Standard Chartered kaufen | S&P Capital IQ | |
| 05.03.14 | BAT neutral | Société Générale Group S.A. (SG) | |
| 05.03.14 | BP overweight | JP Morgan Chase & Co. | |
| 05.03.14 | BAT neutral | Independent Research GmbH | |
| 05.03.14 | Glencore buy | Deutsche Bank AG | |
| 05.03.14 | BP Neutral | UBS AG | |
| 05.03.14 | Glencore Neutral | UBS AG | |
| 05.03.14 | BP Equal-Weight | Morgan Stanley | |
| 05.03.14 | BP Neutral | Citigroup Corp. | |
| 05.03.14 | BP Neutral | Goldman Sachs Group Inc. | |
| 04.03.14 | Barclays kaufen | Deutsche Bank AG | |
| 04.03.14 | AstraZeneca halten | Deutsche Bank AG | |
| 04.03.14 | GSK halten | Deutsche Bank AG | |
| 04.03.14 | Standard Chartered halten | Goldman Sachs Group Inc. | |
| 04.03.14 | BAT halten | Goldman Sachs Group Inc. | |
| 04.03.14 | Barclays halten | UBS AG | |
| 03.03.14 | AstraZeneca verkaufen | Merrill Lynch & Co., Inc. | |
| 03.03.14 | Rio Tinto kaufen | Citigroup Corp. | |
| 03.03.14 | Standard Chartered verkaufen | Morgan Stanley | |
| 28.02.14 | BAT kaufen | Citigroup Corp. | |
| 28.02.14 | BAT kaufen | Nomura | |
| 28.02.14 | Glencore halten | UBS AG |